Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,121 | -38,837 | -14,063 | 29,611 | -10,084 |
| Depreciation Amortization | 39,596 | 529 | 613 | 866 | 987 |
| Income taxes - deferred | -16,185 | N/A | N/A | N/A | N/A |
| Accounts receivable | 628 | -1,887 | 889 | -190 | 2,397 |
| Other Working Capital | -14,631 | 16,519 | 2,298 | -2,449 | 1,116 |
| Other Operating Activity | -3,072 | 11,255 | 3,526 | 5,070 | -2,247 |
| Operating Cash Flow | $-54,785 | $-12,421 | $-6,737 | $32,908 | $-7,831 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,645 | -41,982 | N/A | N/A | N/A |
| PPE Investments | -2,287 | -976 | -725 | -12 | -60 |
| Net Acquisitions | 324 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $7,682 | $-42,958 | $-725 | $-12 | $-60 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 143,870 | 60,676 | 32,716 | 4,547 | 4,610 |
| Financing Cash Flow | $143,870 | $60,676 | $32,716 | $4,547 | $4,610 |
| Exchange Rate Effect | -2,175 | -1,827 | -3,561 | 550 | -100 |
| Beginning Cash Position | 72,187 | 68,717 | 47,024 | 9,031 | 12,413 |
| End Cash Position | 166,779 | 72,187 | 68,717 | 47,024 | 9,031 |
| Net Cash Flow | $94,592 | $3,470 | $21,693 | $37,993 | $-3,382 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,785 | -12,421 | -6,737 | 32,908 | -7,831 |
| Capital Expenditure | -2,287 | -1,056 | -725 | -15 | -60 |
| Free Cash Flow | -57,072 | -13,477 | -7,462 | 32,893 | -7,891 |